Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]

Mycoplasma Pneumonia Antigen Test [Immunochromatography]

½ÅÀÇ·á±â¼úÆò°¡ º¸°í¼­ 2017³â 1±Ç 49È£ p.1 ~ 63
±è¼®Çö, ±è¼ö¿¬, À̹ÎÁø, ±èÁøÇü, °í·ÁÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼®Çö ( Kim Seok-Hyun ) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø
±è¼ö¿¬ ( Kim Su-Yeon ) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø
À̹ÎÁø ( Lee Min-Jin ) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø
±èÁøÇü ( Kim Jin-Hyeong ) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø
°í·ÁÁø ( Ko Ryeo-Jin ) - Çѱ¹º¸°ÇÀǷῬ±¸¿ø

Abstract

½Åû±â¼ú: ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]

¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý](Mycoplasma Pneumonia Antigen Test [Immunochromatography])´Â ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿° ÀǽÉȯÀÚÀÇ Àεεµ¸»¾× ÁßÀÇ ¸¶ÀÌÄÚÇöóÁ Ç׿øÀ» ¸é¿ªÅ©·Î¸¶Åä±×·¡ÇǹýÀ¸·Î Á¤¼º°Ë»çÇÏ¿© ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿°¿©ºÎ¸¦ Áø´ÜÇϱâ À§ÇÑ °Ë»ç·Î, ÀÇ·á¹ý Á¦53Á¶ ¹× ½ÅÀÇ·á±â¼úÆò°¡¿¡ °üÇÑ ±ÔÄ¢ Á¦3Á¶ÀÇ ±ÔÁ¤¿¡ µû¶ó ¡°¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ (Mycoplasma Pneumonia Test)¡±¶ó´Â ¸íĪÀ¸·Î 2017³â 3¿ù 8ÀÏ¿¡ ½ÅûµÇ¾ú´Ù. ÀÌÈÄ ¼ÒÀ§¿øÈ¸¿¡¼­´Â µ¿ °Ë»çÀÇ ±¸Ã¼ÀûÀÎ °Ë»ç¹æ¹ýÀ» °í·ÁÇÏ¿© ¡°¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]¡±·Î ±â¼ú¸íÀ» º¯°æÇÏ¿´´Ù.


½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸ ¹× ¼ÒÀ§¿øÈ¸ ¿î¿µ

2017³â Á¦4Â÷ ½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸(2017.4.28.)¿¡¼­´Â µ¿ ±â¼úÀÇ ¾ÈÀü¼º?À¯È¿¼º¿¡ ´ëÇÏ¿© Áø´Ü°Ë»çÀÇÇаú 3ÀÎ, È£Èí±â³»°ú 3ÀÎ, ¼Ò¾ÆÃ»¼Ò³â°ú(È£Èí±â) 1ÀÎ ÃÑ 7ÀÎÀÇ Àü¹®°¡·Î ±¸¼ºµÈ ¼ÒÀ§¿øÈ¸¸¦ ÅëÇØ Æò°¡Çϵµ·Ï ½ÉÀÇÇÏ¿´´Ù.

¼ÒÀ§¿øÈ¸¿¡¼­´Â 2017³â 7¿ù 27ÀϺÎÅÍ 2017³â 8¿ù 31ÀϱîÁö ÃÑ 2ȸÀÇ È¸ÀǸ¦ ÅëÇØ ¼±ÅÃµÈ ¿¬±¸ÀÇ °á°ú¿¡ µû¶ó µ¿ °Ë»ç¸¦ Æò°¡ÇÏ°í °ËÅä°á°ú¸¦ Á¦ÃâÇÏ¿´À¸¸ç, 2017³â Á¦9Â÷ ½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸(2017.9.22.)¿¡¼­ µ¿ ³»¿ëÀ» Åä´ë·Î µ¿ ±â¼úÀÇ ¾ÈÀü¼º ¹× À¯È¿¼º Æò°¡°á°ú¸¦ ÃÖÁ¾ ½ÉÀÇÇÏ¿´´Ù.


¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý] Æò°¡

Æò°¡¹è°æ ¹× ¸ñÀû
¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]´Â ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿° ÀǽÉȯÀÚÀÇ Àεεµ¸»¾× ÁßÀÇ ¸¶ÀÌÄÚÇöóÁ Ç׿øÀ» ¸é¿ªÅ©·Î¸¶Åä±×·¡ÇǹýÀ¸·Î Á¤¼º°Ë»çÇÏ¿© ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿°¿©ºÎ¸¦ Áø´ÜÇϱâ À§ÇÑ °Ë»ç·Î, µ¿ ±â¼úÀÇ ¾ÈÀü¼º ¹× À¯È¿¼ºÀ» Æò°¡ÇÏ¿´´Ù.

Æò°¡¹æ¹ý
¹®Çå°Ë»öÀº KoreaMed¸¦ Æ÷ÇÔÇÑ 8°³ ±¹³» µ¥ÀÌÅͺ£À̽º¿Í Ovid-MEDLINE, Ovid-EMBASE ¹× Cochrane LibraryÀÇ ±¹¿Ü µ¥ÀÌÅͺ£À̽º¸¦ ÀÌ¿ëÇÏ¿´´Ù. °Ë»öÀü·«¿¡ µû¶ó (¡®exp Pneumonia, Mycoplasma/ or mycoplasma pneumonia*.mp.¡¯) AND (¡®exp Immunochromatography/ or Immunochro-matograph*.mp.¡¯ OR ¡®ICA.mp.¡¯)ÀÇ °Ë»öÀü·« ¹× ¼ö±â°Ë»öÀ» ÅëÇØ ÃÑ 38ÆíÀÇ ¹®ÇåÀ» °Ë»öÇÏ¿´°í, Áߺ¹°Ë»öµÈ ¹®Çå 11ÆíÀ» Á¦¿ÜÇÑ 27ÆíÀ» Åä´ë·Î ¼±Åà ¹× ¹èÁ¦±âÁØÀ» Àû¿ëÇÑ °á°ú ÃÑ 5ÆíÀÇ ±¹¿Ü¹®ÇåÀÌ ÃÖÁ¾Æò°¡¿¡ Æ÷ÇԵǾú´Ù.

¹®Çå°Ë»öºÎÅÍ ¼±ÅñâÁØ Àû¿ë ¹× ÀÚ·áÃßÃâ±îÁö °¢ ´Ü°è´Â ¸ðµÎ ¼ÒÀ§¿øÈ¸ ¹× 2¸íÀÇ Æò°¡ÀÚ°¡ µ¶¸³ÀûÀ¸·Î ¼öÇàÇÏ¿´´Ù. ¹®ÇåÀÇ Áú Æò°¡´Â Scottish Intercollegiate Guidelines NetworkÀÇ µµ±¸¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç, ÀÌ¿¡ µû¶ó Áú Æò°¡ °á°ú¿Í ±Ù°ÅÀÇ ¼öÁØÀ» ¼±Á¤ÇÏ¿© Æò°¡°á°ú¸¦ ±â¼úÇÏ¿´´Ù.

Æò°¡°á°ú
µ¿ ±â¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀº ÃÑ 5ÆíÀÇ Áø´Ü¹ý Æò°¡¿¬±¸(±¹¿Ü ¹®Çå 5Æí)¸¦ ±Ù°Å·Î Æò°¡ÇÏ¿´´Ù.

¾ÈÀü¼º
µ¿ ±â¼úÀÇ ¾ÈÀü¼º Æò°¡°á°ú, µ¿ °Ë»ç´Â ȯÀÚÀÇ Àεεµ¸»¾× °Ëü¸¦ äÃëÇÏ¿© ü¿Ü¿¡¼­ ÀÌ·ç¾îÁö´Â °Ë»çÀ̹ǷÎ, ´ë»óÀÚ¿¡°Ô Á÷Á¢ÀûÀÎ À§Çظ¦ °¡ÇÏÁö ¾ÊÀ¸¹Ç·Î °Ë»ç ¼öÇà¿¡ µû¸¥ ¾ÈÀü¼º¿¡´Â ¹®Á¦°¡ ¾ø´Ù°í Æò°¡ÇÏ¿´´Ù.

À¯È¿¼º
µ¿ ±â¼úÀÇ À¯È¿¼ºÀº 5ÆíÀÇ ¹®ÇåÀ» ±Ù°Å·Î Âü°íÇ¥Áذ˻ç(ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ¹ý)¸¦ ±âÁØÀ¸·Î ÇÑ Áø´ÜÁ¤È®¼ºÀ¸·Î Æò°¡ÇÏ¿´´Ù.

ÁßÀç°Ë»çÀÇ Áø´ÜÁ¤È®¼ºÀº ¹Î°¨µµ 0.58 ~ 0.81, ƯÀ̵µ 0.88 ~ 1.00, ¾ç¼º¿¹Ãøµµ 0.33 ~ 1.00, À½¼º¿¹Ãøµµ 0.89 ~ 0.97, °Ë»çÁ¤È®µµ 0.85 ~ 0.93À¸·Î º¸°íµÇ¾ú´Ù.

ÀÌ¿¡ ¼ÒÀ§¿øÈ¸¿¡¼­´Â ±âÁ¸ÀÇ Ç÷û Ç×ü °Ë»ç´Â °¨¿° ÈÄ Ç×ü»ý¼º±îÁö ¸¹Àº ½Ã°£ÀÌ ¼Ò¿äµÇ°í Ä¡·á ÈÄ¿¡µµ ÀÜ¿© Ç×ü°¡ ³²¾Æ ÀÖ´Â °æ¿ì°¡ ÀÖ¾î °¨¿° ¿©ºÎ¿¡ ´ëÇÑ Á¤È®ÇÑ Áø´ÜÀÌ ¾î·Æ°í, Âü°íÇ¥Áذ˻çÀÎ ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ¹ýÀº °Ë»ç °á°ú¸¦ È®ÀÎÇϴµ¥ 1 ~ 2ÀÏ Á¤µµ ¼Ò¿äµÇ¾î °¨¿°¿©ºÎ¸¦ ½Å¼ÓÇÏ°Ô È®ÀÎÇÒ ¼ö ¾øÀ¸³ª, µ¿ °Ë»ç´Â °£ÆíÇÏ°í ½Å¼ÓÇÏ°Ô °Ë»ç¸¦ ¼öÇàÇÒ ¼ö ÀÖ¾î À¯¿ë¼ºÀÌ ÀÖ°í, Áø´ÜÁ¤È®¼ºÀÌ ÀÓ»óÀûÀ¸·Î ¼ö¿ë °¡´ÉÇÑ ¼öÁØÀ̶ó´Â ÀǰßÀ̾ú´Ù.

°á·Ð

µû¶ó¼­ ¼ÒÀ§¿øÈ¸¿¡¼­´Â ÇöÀç ¹®ÇåÀû ±Ù°Å¸¦ ¹ÙÅÁÀ¸·Î ´ÙÀ½°ú °°ÀÌ Á¦¾ðÇÏ¿´´Ù.

¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]´Â ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿° ÀǽÉȯÀÚ¸¦ ´ë»óÀ¸·Î ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿°¿©ºÎ¸¦ Áø´ÜÇϱâ À§ÇÑ °Ë»ç·Î ¾ÈÀü¼º ¹× À¯È¿¼º¿¡ ´ëÇÑ ±Ù°Å°¡ ÀÖ´Â °Ë»ç·Î Æò°¡ÇÏ¿´´Ù(±Ù°ÅÀÇ ¼öÁØ C).

½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸´Â ½ÅÀÇ·á±â¼úÆò°¡¿¡ °üÇÑ ±ÔÄ¢ Á¦3Á¶Á¦6Ç׿¡ ÀǰŠ¡°¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]¡±¿¡ ´ëÇÑ ¼ÒÀ§¿øÈ¸ °ËÅä°á°ú¿¡ ±Ù°ÅÇÏ¿© ´ÙÀ½°ú °°ÀÌ ½ÉÀÇÇÏ¿´´Ù(2017.9.22.).

¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ Ç׿ø °Ë»ç [¸é¿ªÅ©·Î¸¶Åä±×·¡Çǹý]´Â ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿° ÀǽÉȯÀÚ¸¦ ´ë»óÀ¸·Î ¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ °¨¿°¿©ºÎ¸¦ Áø´ÜÇϴµ¥ ¾ÈÀü¼º ¹× À¯È¿¼ºÀÌ ÀÖ´Â ±â¼úÀÌ´Ù(±Ù°ÅÀÇ ¼öÁØ C).

½ÅÀÇ·á±â¼úÆò°¡À§¿øÈ¸ ½ÉÀǰá°ú´Â ¼ÒÀ§¿øÈ¸ÀÇ °ËÅä°á°ú¿Í ÇÔ²² 2017³â 10¿ù 18ÀÏ º¸°Çº¹ÁöºÎ Àå°ü¿¡°Ô º¸°íµÇ¾úÀ¸¸ç, º¸°Çº¹ÁöºÎ °í½Ã Á¦2017-186È£(2017.11.23.)·Î °³Á¤ °í½Ã µÇ¾ú´Ù.

Ű¿öµå

¸¶ÀÌÄÚÇöóÁ ´º¸ð´Ï¾Æ; Ç׿ø °Ë»ç; ¾ÈÀü¼º; À¯È¿¼º
Mycoplasma Pneumonia; Antigen Test; Safety; Effectiveness

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸